| Date Filed | Type | Description |
| 05/18/2023 |
4
| MACARTNEY LAWSON (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Sold 16,000 shares
@ $24, valued at
$384k
Exercised 16,000 options to buy
@ $1.19, valued at
$19k
|
|
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 01/04/2023 |
4
| MACARTNEY LAWSON (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $8.52, valued at
$187.4k
|
|
| 01/05/2022 |
4
| MACARTNEY LAWSON (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $4.88, valued at
$107.4k
|
|
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2018 |
4
| MACARTNEY LAWSON (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Bought 47,965 shares
@ $5.219, valued at
$250.3k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |